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SUMMARY
Controversy exists concerning the appropriate use ofcarbohydrate solutions and
fat emulsions as energy sources in intravenous nutritional regimens. Current
evidence suggests that glucose is the carbohydrate energy source ofchoice and
that when infused with appropriate quantities ofprotein it provides cheap and
effective nutritional support in the majority ofpatients and clinical circumstances.
During glucose infusion, bloodglucose and acid -base balance should be closely
monitored and, when indicated, exogenous insulin should be added to the
regimen to combat hyperglycaemia and improve protein anabolism. Fat
emulsions, although expensive, may justifiably be used in patients with
moderate or severe stress toprovide up to 50% ofnon-protein energy, especially
in circumstances where attempts to satisfy energy requirements exclusively with
glucose would impose an additional metabolic stress.
INTRODUCTION
Intravenous nutrition is regarded as one of the most significant advances in
medical and surgical management during the past 20 years. Several studies have
documented a high incidence of clinical and sub clinical malnutrition in
hospitalised patients,1' 2 which is associated with increased morbidity and
mortality. These complications of medical and surgical disease may be reduced
by the appropriate provision of nutritional support by oral, enteral, or parenteral
route. The therapeutic nutritional regimen should provide adequate protein and
energy substrates to replete and maintain adequate nutrition and to match the
increased metabolic demands of illness and infection.3 The formulation of an
intravenous regimen is based on the use of solutions containing essential and
non-essential crystalline amino acids to provide protein requirements, the use of
carbohydrate solutions or fat emulsions or a combination of both to provide
energy, and the addition of minerals, vitamins, and trace elements to satisfy daily
requirements. Although a standardised regimen containing about equal
proportions ofcrystalline amino acids and dextrose with appropriate additives will
satisfy the nutritional requirements of many patients, adjustments may be needed
to meet the increased demand for all nutrients during infection, or to cope with
special problems such as renal failure, hepatic dysfunction, protein intolerance
and the paediatric patient.3 Controversy exists concerning both the composition
of amino acid solutions, and the most appropriate energy source for optimal
utilisation in various diseases. This review discusses the use ofhypertonic glucose
solutions, glucose substitutes, and fat emulsions as energy sources in intravenous
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regimens for the management of hospitalised patients. These regimens are used
in a spectrum of clinical conditions and the metabolism of these nutritional
supplements under normal conditions, in starvation, and in various degrees of
stress will be discussed.
ENERGY REQUIREMENTS
The relative energy requirements in health and disease differ. The basal energy
expenditure of a normal 70kg manat rest isabout 2,000 Kcal per day. Decreased
food intake is accompanied by weight loss and a decrease in basal energy
expenditure. Following elective surgical procedures, in the absence ofsignificant
complications, the post-operative energy expenditure will not ordinarily differ by
more than 10% from pre-operative values. Previously well-nourished patients
with multiple fractures may have an increase in basal energy expenditure of
10 - 25%, and in major infection, such as intra-abdominal abscess or peritonitis,
there may be an increase of up to 50-75% above predicted normal levels.
Sustained higher levels of basal energy expenditure (125%) may occur with
major thermal burns.
The metabolic response to injury is classically described as being separated into
two distinct phases - an acute phase in which there is mobilisation ofendogenous
substrates to provide energy, and an adaptive phase in which metabolism is
dependent on the availability of nutrient substrates. These phases correspond to
the 'ebb' and 'flow' phases of the metabolic response to trauma originally
described by Cuthbertson in 1942.4 The metabolic response to starvation differs
from that of injury and infection, and it is important to realise that, in individual
patients, varying degrees of starvation, injury, and infection may contribute to the
overall changes in hormonal and substrate homoeostasis.
METABOLIC RESPONSE TO STARVATION
The sequence of events leading to death in starvation is usually decreased food
intake, protein wasting, weakness ofrespiratory muscles, atelectasis, pneumonia,
and death. The metabolic response to starvation has an initial and a late phase:
the initial phase is directed toward maintaining glucose production to meet the
needs of the brain, nervous tissue, and red blood cells (gluconeogenic phase),
and the late phase toward minimising the rate of protein breakdown (protein -
conservation phase). Fat derived from adipose tissue stores is the main
endogenous fuel in all but the postprandial state and satisfies 85% ofdaily energy
needs in prolonged fasting. During starvation, in the absence of an exogenous
carbohydrate supply, there is an increase in glucose production and a reduction
in extracerebral glucose utilisation. Blood glucose concentration declines and
results in decreased circulating insulin and glucagon which stimulates lipolysis
(providing non -esterified fatty acids for energy requirements of muscle and liver)
and hepatic ketogenesis. Liver and muscle glycogen stores rapidly become
depleted, and glucose production subsequently depends on gluconeogenesis
from lactate and amino acids, principally alanine and glutamine from muscle
protein. During the initial 72 hours of starvation, alanine output increases and
hepatic glucose output is able to keep pace with the rapid rates of glucose
utilisation in the brain. Pyruvate, lactate, and the glycerol skeleton of triglyceride
are also used as gluconeogenic substrates. If fasting extends beyond one week,
nitrogen loss progressively declines and there is a reduction of hepatic
gluconeogenesis. Blood glucose levelsremain unchanged and thereisa reduction
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in glucose utilisation. These changes are accompanied by an increase in
circulating ketone bodies, which are formed from fatty acids in the liver. There is
a reduced need for gluconeogenesis which is reflected in a decreased output of
alanine from muscle.
METABOLIC RESPONSE TO INJURY AND INFECTION
Following the stress of injury or infection, the pattern of endogenous fuel
substrate utilisation differs from that observed in uncomplicated starvation. The
most obvious differences are protein wastage, hyperglycaemia, and anaerobic
glycolysis with lactate production. Injury induces a wide range of integrated
changes in haemodynamics, neuroendocrine secretions (in particular, insulin,
glucagon, corticosteroids, and catecholamines), and tissue metabolism. Provided
that the injury is not fatal, the immediate phase of depressed local metabolism is
followed bya period of increased general metabolism dueto theincreased cellular
activity of the repair process, elimination of damaged and devitalised tissue, and
increased catabolism of protein. There is also increased oxygen consumption and
heat production, and the increased nitrogen excretion closely parallels the
increased energy expenditure.
The changes in energy metabolism are most important for survival and repair.
There is increased sympathetic activity for 48-72 hours which ensures an
adequate mobilisation of carbohydrate and fat stores, resulting in hyperglycaemia
and increased plasma non
-esterified fatty acids, but the rates ofoxidation of both
substrates are unaltered. Following the acute reaction to injury, which may last up
to 72 hours, there is an increase in heat production and rise in body temperature
associated with an increase in urinary excretion of nitrogen, inorganic sulphate,
phosphate, potassium, and creatinine. The excess nitrogen is derived from
catabolism of muscle protein and the oxidation of non-nitrogenous residues
accounts for some of the extra heat production. This obligatory protein loss
cannot be completely abolished in the immediate post-traumatic period, even
with large intake of protein and calories. Protein catabolism is accelerated to a
greater extent than protein anabolism and the prolonged proteolysis of muscle
protein leads to excessive hepatic gluconeogenesis, depletion of muscle protein,
weakness, reduction of protein synthesis, diminished enzyme function, and loss
of immunocompetence.
Hyperglycaemia and a diabetic glucose-tolerance curve are characteristic of
the response to injury and infection, despite a normal insulin response to
hyperglycaemia. Glucose uptake by the tissues is unaltered, suggesting insulin
resistance in the tissues. Adipose tissue still responds to hyperinsulinaemia by
suppression of lipolysis. Alanine, lactate, and glycerol all provide an increasing
flow of gluconeogenic substrate to the liver which releases more glucose under
the influence ofalanine-induced hyperglucagonaemia. There may be impairment
of uptake of other metabolic fuels (non-esterified fatty acids, ketone bodies)
leading to the oxidation of branched-chain amino acids derived from muscle
protein to satisfy the local energy requirements of muscle. Thus, hyperglycaemia
reflects an augmentation of the glucose pool to maintain glucose oxidation rates
rather than a need for overall energy provision from proteolysis. Although the
nitrogen excretion following injury parallels the increased resting metabolic
expenditure and weight loss, the energy contribution ofprotein isonly about 20%
of daily expenditure, the residual energy requirement being met by mobilisation
of fat stores.
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ENERGY PROVISION
Thesubstrate and hormone changes that characterise the responses to starvation,
injury and infection are designed initially to ensure survival and subsequently to
initiate repair processes at the expense of endogenous tissue stores, which further
compromises host metabolism. It is against this complex biochemical back-
ground that nutritional support of the hospitalised patient is usually undertaken.
Intravenous nutritional regimens are designed to replenish existing deficiencies,
to minimise further tissue consumption, and to provide sufficient energy and
protein substrates to stimulate and maintain anabolism and repair. An important
limiting factor of intravenous nutrition is the ability of tissues to metabolise
the infused nutrients: on the one hand, there is the requirement for large
quantities of exogenous nutrient substrates to satisfy nutrient requirements while,
on the other hand, local and general metabolic responses to starvation, injury and
infection may reduce the efficient utilisation of those substrates. This may lead to
unnecessary complications of therapy such as the over-enthusiastic infusion of
hypertonic glucose solutions to the septic patient leading to worsening of pre-
existing hyperglycaemia, excessive glycosuria, osmotic diuresis, increased fluid
and electrolyte losses, dehydration, and non-ketotic coma. The most important
determinant of outcome in a patient receiving nutrition exclusively by vein is
the ability to supply and metabolise sufficient protein to compensate for the
catabolism of endogenous protein, to synthesise acute phase proteins, to
maintain immunocompetence, and to preserve the integrity of major organ
systems. Protein economy and the utilisation of exogenous crystalline amino
acids improves as non-protein energy provision increases and thus the success or
failure of a nutritional regimen is dependent on the appropriate choice of a non-
protein energy source.
There are essentially three practical methods of delivering non-protein energy
in intravenous regimens - glucose, glucose substitutes, or lipids. Glucose is
available in concentrations from 5 % to 70% and may be used exclusively as the
energy source provided minimal amounts of fat are given to avoid essential fatty
acid deficiency. Glucose substitutes - fructose, sorbitol, xylitol
- also are
available in a range of concentrations, but they appear to have no particular
advantage over glucose. Fat emulsions (10% or 20%) have a high energy value,
but the daily dosage should not exceed 2.5g/kg body weight and should not
make up more than 60% of the total energy intake. Each regimen has its
advocates, but rational choice of an energy source has to take into consideration
the type of patient, disease process, therapeutic goal, expense, substrate
utilisation, method of delivery, and potential complications.
GLUCOSE
The average oral diet contains about 45 % carbohydrate and 40% fat, and
together these two energy-yielding substrates supply approximately 90% of daily
energy requirements. Glucose infusions are used extensively in surgical practice,
both to maintain hydration together with electrolyte solutions and as a source of
energy. Glucose can be metabolised by all the tissues of the body and it is a pre-
requisite for protein anabolism. A normal person can assimilate up to800g of
glucose per day, but glucose is taken up by muscle and adipose tissue only in the
presence of insulin. Many studies have documented improvement in cardiac,
respiratory, and hepatic function as well as improvement in cellular function as a
result of glucose infusion both with and without exogenous insulin. (Table 1).
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TABLE I
Relative merits ofintravenous glucose
Advantages
- Readily available in a wide range of concentrations 5 - 70%
- Easily stored
Cheap
- Stimulates endogenous insulin production
Reduces proteolysis and gluconeogenesis
Disadvantages
Hypertonic solutions require central infusion
Glucose intolerance may require exogenous insulin
Osmotic diuresis
Lack of fat and essential fatty acids
- Hepatotoxicity
Stimulates fat synthesis
Increased C02 production
Central venous thrombosis
Septicaemia and bacterial infection
- Metabolic complications (acidosis, hypophosphataemia)
Glucose solutions are readily available in a wide range of concentrations from 5%
to 70%. They are cheap and are easily stored. Five and 10% solutions may be
infused via peripheral lines but higher concentrations require the use of a central
vein with the inherent risks of mechanical complications and infection. Because
of the range of concentrations available, each regimen may be tailored to the
energy requirements of individual patients. Glucose infusion stimulates insulin
production from the pancreas which enhances protein anabolism and reduces
proteolysis and gluconeogenesis. In many patients, glucose may be used as the
sole energy source.
The disadvantages of glucose as an intravenous energy source are usually related
totwo factors - firstly, the supplyofglucose in excessofthe energy requirements,
and, secondly, changes in body metabolism as a result of injury and infection
which interfere with the cellular metabolism of glucose. These conditions may
produce hyperglycaemia and osmotic diuresis leading to fluid, electrolyte, and
acid-base imbalance and requiring the use of exogenous insulin to maintain
normoglycaemia. Excessive intravenous glucose may also lead to impairment of
biochemical liver function tests, increased fat synthesis and deposition, hypo-
phosphataemia, and increased C02 production. Due to the hypertonicity of the
solutions, central venous thrombosis may occur and bacterial contamination with
septicaemia is common unless a strict protocol is followed for the management of
central venous lines. Infusion regimens that contain no fat will lead to essential
fatty acid deficiency after several weeks. Concentrated glucose infusions should
always be given with an adequate protein intake to avoid the development of
'iatrogenic kwashiorkor'.
The energy requirements in starvation and nutritional depletion without stress are
relatively easily supplied by glucose infusion alone. However, there is an upper
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limit to the rate of glucose oxidation, and endogenous fat continues to be used for
a portion of the total energy requirements.5 Excess glucose is converted to fat
which is inefficient as lipogenesis consumes energy that is not recovered during
subsequent lipolysis. In mild and moderate stress, thereisusually hyperglycaemia
due to increased gluconeogenesis rather than reduced glucose oxidation.6
Glucose infusion will not completely abolish gluconeogenesis and fat oxidation
and mobilisation of endogenous fat continues even when glucose is supplied in
quantities that satisfy energy requirements. Large glucose loads may also
decreasefree fattyacid oxidation and causeadditional stress byincreasing oxygen
consumption and carbon dioxide production and norepinephrine excretion in the
urine.7 Intolerance to glucose may be even more pronounced in the severely
stressed critically ill patient and large quantities of exogenous insulin may be
required.
Intravenous regimens containing crystalline amino acids and glucose as the non-
protein energy source have been shown to improve nitrogen balance in a number
of disease states and clinical situations.8 9, 10 The weight of evidence from clinical
studies shows that, with adequate protein intake, nitrogen retention and utilisation
improves as energy intake increases, until energy requirements are satisfied.IO 11
Energy supply in excess of requirements produces no additional nitrogen
sparing and may give rise to significant biochemical, hepatic, and respiratory
complications.8 12, 13
GLUCOSE SUBSTITUTES
Fructose, sorbitol, and xylitol have been suggested as alternative intravenous
sources of carbohydrate when hyperglycaemia and significant losses of glucose
in the urine are features of the metabolic response to injury and infection. This
recommendation is based on their rapid metabolism compared with that of
glucose, their 'insulin independence' and their similar protein and antiketogenic
effects. However, studies of their comparative metabolism show that the term
'insulin independence' is misleading, as these substrates are rapidly converted
to glucose in the liver, and further metabolism by extrahepatic tissues requires
the presence of insulin.14 The theoretical advantages of these solutions would
therefore appear to be unfounded and are outweighed by their disadvantages. At
high rates of infusion, significant metabolic acidosis, hypophosphataemia, and
hyperuricaemia may occur, particularly in patients who are nutritionally depleted
or who already have elevated plasma lactate levels as a result of their disease
process.15 If these solutions are used, they should be used cautiously and their
infusion rates should not exceed 0.5g/kg body weight/hour or they should be
used in combination with glucose to minimise the risk of complications.16 17
However, the ease of monitoring blood glucose, glycosuria, and acid -base
balance, and the use of appropriate exogenous insulin therapy when indicated
suggests that glucose is the carbohydrate energy source of choice in intravenous
regimens. The therapeutic success of glucose and insulin therapy in patients who
are critically ill and severely stressed leaves few indications for the clinical use of
glucose substitutes.'8
FAT
Fat emulsions have been used extensively in intravenous regimens in Britain and
Europe for many years, but it is only in recent years that extensive experience of
the use of fat as an intravenous energy source has been obtained in the United
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TABLE II
Relative merits ofintravenous fats
Advantages
Available in 10% or 20% emulsion
Isotonic and may be infused peripherally
Source of essential fatty acids
High energy density
No metabolic complications
Disadvantages
Expensive
Not recommended as sole energy source
Not 'protein-sparing' when used alone
Hyperlipaemia
May inhibit white blood cell functions
Hepatotoxicity
Impaired pulmonary diffusion capacity
Fungal infections
Alterations in coagulation and thrombocytopenia
States. Emulsions of 10% or 20% soy-bean or cotton-seed oil are available,
which are isotonic, have a high energy density, and may be infused via a
peripheral vein. It is recommended that the infusion rate should not exceed
2.5g/kg body weight/day and that fat should provide no more than 60% of the
non-protein energy. Fat emulsions provide a source of essential fatty acids and
deficiency can be prevented by supplying approximately 5% of energy require-
ments as polyunsaturated fat by the intravenous or enteric route. Apart from
hyperlipaemia, there are few metabolic complications, although hepatotoxicity,
inhibition of white cell function, coagulation defects, and thrombocytopenia may
all occur. A further limiting factor is their expense in comparison with hypertonic
glucose. (Table I1).
When used alone, fat isnot protein-sparing, the minimal improvementin nitrogen
sparing being accounted for by the free glycerol present in the fat emulsion.19'20
In starved and nutritionally depleted patients, similar nitrogen balances have been
observed in groups of patients receiving the same total energy and nitrogen
intake when 83% of their non -protein energy was either lipid or hypertonic
glucose.21 In stressed hypermetabolic patients, there is a progressive decrease
in nitrogen retention as the percentage of total energy provided by glucose
decreases and by fat emulsion increases.8 Other studies have shown similar
nitrogen-sparing effects of the lipid and glucose systems in moderately injured,
infected, and malnourished patients and it has been suggested that the choice
between the regimens should be based on factors other than ability to improve
nitrogen balance.22 In the critically ill patient, at least two-thirds of the measured
or predicted metabolic requirements should be supplied as glucose, and fat
emulsions should be used as a source of essential fat and to stabilise body fat
mass and increase body weight. In starvation, lipid clearance from the blood
stream and its use as an energy source is very similar to the chylomicron and
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appears to be enhanced by the simultaneous administration of glucose. In
moderate stress, there is more complete oxidation of exogenous lipid and no
additional stress associated with increased oxygen consumption, C02 production,
and norepinephrine excretion or fatty liver seen in patients receiving glucose
infusion for prolonged periods. In severe stress, the ability to clear fat emulsions is
markedly impaired and fat oxidation is reduced.
ENERGY SOURCES - GLUCOSE VERSUS FAT
The non-protein energy requirements of an intravenous diet may be supplied by
hypertonic glucose solutions or fat emulsions. In all situations, glucose is the
carbohydrate energy source of choice as it is inexpensive, associated metabolic
acidosis is unusual, and hyperglycaemia is easily treated with exogenous insulin.15
In normal and starved patients, equal energy fat and carbohydrate regimens with
amino acids produce similar nitrogen balances.21'23 In hypermetabolic patients
with burns or infection, carbohydrate appears to have a greater impact on
nitrogen retention than does fat. Nitrogen retention improves as carbohydrate
intake increases, provided that total energy intake matches total metabolic
expenditure.8 The nitrogen -sparing effect of carbohydrate appears to be
mediated through insulin, and additional nitrogen retention may be achieved with
exogenous insulin.24 The explanation of this apparent difference between fat
and carbohydrate as energy sources in hypermetabolic patients is related to
the muscle fuel deficit that exists secondary to a failure of keto -adaptive
mechanisms and suppression of hepatic ketone body output by glucose. In
addition, inflammatory tissues are glycolytic and have a major capacity for
anaerobic metabolism. Endogenous fat is the primary fuel for skeletal muscle and
hepatic gluconeogenesis, while glucose and lactate provide energy for the injured
tissues.25 Thus, fat emulsions will stabilise body fat and serve as an exogenous
fuel, but will not affect nitrogen balance, whereas exogenous glucose stimulates
insulin which reduces muscle proteolysis and nitrogen excretion.
Although fat emulsions appear to have limitations as energy sources in hyper -
catabolic, injured, or septic adults, it is important that some fat be given in
depleted states to ensure that essential fatty acid deficiency does not occur. Skin
rashes, thrombocytopenia, increased haemolysis, and impaired wound healing
may appear after a period of several weeks of fat-free intravenous nutrition. The
clinical abnormalities are accentuated by growth in children and the hyper-
metabolism of infection and are associated with low serum levels of essential
polyunsaturated fats and a compensatory increase of saturated fatty acids. The
ratio of the trienoic and tetraenoic fatty acids rises in deficiency states and may
be used as a guide to the adequacy of replacement therapy with intravenous
fat emulsions. Deficiency may be prevented by supplying approximately 4% of
total energy requirements as polyunsaturated fat. In infected patients receiving
intravenous nutrition with no oral intake, 500ml of fat emulsion(Intralipid 10%)
may be given on alternate days to satisfy this requirement and the triene/tetraene
ratio is measured at intervals. Small amounts of polyunsaturated fat (safflower oil)
may be given by tube if the enteric route is available.
Fat and carbohydrate may also have differing effects on body composition
measurements. Although intravenous hyperalimentation is often associated with
weight gain and positive nitrogen balance, it is only recently that direct measure-
ment of changes in body composition has contributed to our knowledge of the
tissue changes involved. A study of the relative merits of glucose and fat as
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energy sources showed that in two groups ofpatients with gastrointestinal disease
requiring intravenous nutrition, marked differences in body composition were
noted after a two-week infusion period with the substrates.17 The group receiving
dextrose asits sole energy source gained weight due to gains in bodyfat and body
water, but in the group which received 60% of its non-protein energy as fat, there
was a significant gain of protein but not water and fat. The authors suggested that
the differences in water retention might be particularly significant to the critically
ill patient and indicated that more studies were necessary to define the respective
roles of fat and carbohydrate as energy sources in several clinical situations. The
ability to preserve muscle and visceral protein mass and stimulate anabolism is
critical to the successful outcome of hypermetabolic illness, and it appears that
this goal may be achieved with an adequate protein intake, and a modest energy
excess utilising a range of nutrient mixtures.27 28
The septic and injured patient seems to utilise endogenous fat preferentially as an
energy source even when dextrose is administered in quantities above energy
expenditure. Administration of a large dextrose load to hypermetabolic patients
does not suppress net fat oxidation as it does in the depleted patient, but there is
an increase in oxygen consumption, continued oxidation offat, and an increase in
the conversion of glucose to glycogen.7 This is associated with an increase in C02
production which is not seen when fat emulsions are used. The excess C02 has
to be excreted by the lungs, and in patients with infection and compromised
pulmonary function, respiratory distress may be precipitated. In this situation,
a large dextrose intake may represent an additional physiological stress. Fat
emulsions must be used with caution in a patient with respiratory distress or
'shocked lung', as fat emboli may occur, further compromising respiratory
performance.
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